The motor function benefits of Itvisma (onasemnogene abeparvovec-brve), one of two Novartis’ gene therapies for spinal muscular…
Articles by Lila Levinson, PhD
Up to three years of treatment with Evrysdi (risdiplam) appears safe and was associated with presymptomatic children with…
A high-dose regimen of Spinraza (nusinersen) that is up for regulatory approval in the U.S. may help stabilize or…
Salanersen, a treatment candidate for spinal muscular atrophy (SMA) now in clinical testing, is safe and was shown…
Genetic screening for spinal muscular atrophy (SMA) in newborns may allow treatment to begin earlier, which could help support…
Apitegromab, a muscle-strengthening therapy for spinal muscular atrophy (SMA), helped improve motor function in a new analysis of…
Modifications that help certain genetic information travel to specific parts of nerve cells can ease motor symptoms and help normalize…
Using a specially designed back brace in addition to taking part in physical therapy may work best to reduce…
A technique to estimate the health of nerve cells that control movement may help predict how strongly some individuals will…
Biogen has acquired Alcyone Therapeutics and will continue to develop ThecaFlex DRx, a device intended to ease patient…